JS BIOFUTURE INVEST ApS: Financial statements 2021
CVR: 31080983
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
JS BIOFUTURE INVEST ApS (CVR 31080983) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -65,800 and a net result of DKK -44,513 compared with DKK 120,224 the year before. Equity in the 2021 report amounted to DKK 252,310. The solvency ratio was 49%.
- Gross Profit
- DKK -65,800
- Profit/Loss
- DKK -44,513
- Equity
- DKK 252,310
- Total Assets
- DKK 515,078
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -66K | -45K | 252K | - |
| 2020 | - | -17K | 120K | 297K | - |
| 2019 | - | -6K | 39K | 52K | - |
| 2018 | - | -4K | -13K | 13K | - |
| 2017 | - | -8K | 3K | 26K | - |
Official annual report
Find more companies like JS BIOFUTURE INVEST ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
JS BIOFUTURE INVEST ApS has published its annual report for 2020. Gross profit came to DKK -17,161, and the net result was DKK 120,224.
About JS BIOFUTURE INVEST ApS
JS BIOFUTURE INVEST ApS is a Danish company of the type Anpartsselskab based in Kgs.Lyngby, founded in 2007. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named ApS KBUS 17 NR. 6222. The management consists of Jørgen Schøller. The company is owned by Jørgen Schøller and Anna Carina Wiborg Simonsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -18,598 and a net result of DKK 1,492,381 compared with DKK -8,609 the year before. Equity in the 2025 report amounted to DKK 1,706,887.